Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

2.45
Delayed Data
As of Sep 02
 0.00 / 0.00%
Today’s Change
0.33
Today|||52-Week Range
5.55
+512.50%
Year-to-Date
No recent news for Nymox Pharmaceutical Corp.

Today’s Trading

Previous close2.45
Today’s openn.a.
Day’s range-- - --
Volume600
Average volume (3 months)955,229
Market cap$91.1M
Dividend yield--
Data as of 09/02/2015

Growth & Valuation

Earnings growth (last year)+7.14%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-12.19%
P/E ratioNM
Price/Sales4.78
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CLCDCoLucid Pharmaceutic...+0.17+2.81%
GLMDGalmed Pharmaceutica...0.000.00%
OHRPOHR Pharmaceutical I...0.000.00%
SNSSSunesis Pharmaceutic...0.000.00%
Data as of 9:35am ET, 09/03/2015

Financials

Next reporting dateNovember 13, 2015
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$2.9M
Annual profit (last year)-$4.6M
Net profit margin-155.76%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer
Erik Danielsen
Corporate headquarters
Saint-Laurent, Quebec

Forecasts

Partner Offers